COMMUNIQUÉS West-GlobeNewswire

Innate Pharma renforce et étend sa collaboration de développement en oncologie avec AstraZeneca
23/10/2018
Innate Pharma fait l'acquisition des droits de commercialisation de l'anti-cancéreux Lumoxiti aux Etats-Unis et en Europe, devenant une société de biotechnologies intégrée AstraZeneca acquiert l'intégralité des droits [...]
MDxHealth Provides Business Update for the first nine months of 2018
23/10/2018
NEWS RELEASE REGULATED INFORMATION INTERIM TRADING UPDATE Product and Service revenue up 29% year-on-year IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, October 23, 2018 - MDxHealth SA ("MDxHealth, or the "Company"), ( [...]
MDxHealth (R): MDxHealth publie son rapport d'activités intermédiaire relatif aux neuf premiers mois de 2018
23/10/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES RAPPORT D'ACTIVITÉS INTERMÉDIAIRE Les revenus liés aux produits et services en hausse de 29 % par rapport à l'année précédente IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST [...]
UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
23/10/2018
BRUSSELS, Belgium and CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Today UCB (Euronext Brussels: UCB) and Biogen Inc . (Nasdaq: BIIB) announced top-line results from a Phase 2b study evaluating the safety and [...]
IntelGenx Completes US$12 Million Equity Offering
23/10/2018
SAINT LAURENT, Quebec, Oct. 22, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “ Company ” or “ IntelGenx ”) is pleased to announce that it has closed its offering (the “ Offering [...]
Novartis announces Lancet publication of pioneering study in migraine prevention showing efficacy of Aimovig® where other treatments have failed
23/10/2018
The LIBERTY trial is the first study of a CGRP-targeted therapy in a patient population where multiple preventive treatments had previously failed Patients treated with Aimovig, reported significant reductions in [...]
Chembio Announces Proposed Public Offering of Common Stock
22/10/2018
MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it [...]
INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5
22/10/2018
PHOENIX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
National Research Corporation to Broadcast its 2018 Third Quarter Conference Call Live on the Internet
22/10/2018
Lincoln, Nebraska, Oct. 22, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 third quarter earnings conference call on [...]
ContraFect to Participate in World Antimicrobial Resistance Congress 2018
22/10/2018
YONKERS, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
MacroGenics Announces Participation in Three Investor Conferences
22/10/2018
ROCKVILLE, MD, Oct. 22, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
22/10/2018
ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, [...]
Chembio Reports Preliminary Third Quarter 2018 Revenue
22/10/2018
Signs Definitive Agreement to Acquire opTricon GmbH MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company [...]
Osmotica Pharmaceuticals plc Announces Closing of Initial Public Offering
22/10/2018
BRIDGEWATER, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the closing of its initial public offering of 7,647,500 ordinary shares at [...]
CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
22/10/2018
ALPHARETTA, Ga., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
22/10/2018
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “ [...]
Akcea Therapeutics to Hold Third Quarter 2018 Financial Results Webcast
22/10/2018
Webcast scheduled for Monday, November 5 th at 4:30 p.m. Eastern Time BOSTON, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that [...]
Aclaris Announces Closing of Public Offering of Common Stock
22/10/2018
WAYNE, Pa., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Evolus Expands Leadership Team with Appointments of Key Executives
22/10/2018
Appoints Kurt Knab as Vice President, Sales Appoints Alejandro “Alex” Sabad as Vice President, Operations Appoints Amy Marinne Fox as Vice President, Human Resources IRVINE, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- [...]

Pages